“…Several efforts have constructed KGs by ingesting and transforming scientific literature, 34,35 some with a few additional types of data also included, such as confirmed case and mortality data; 36 clinical information, drug trial, and sequencing data; 37 drug, drug trial and genome sequence data; 38 diseases, chemicals, and genes 39 . Other KG efforts ingest a wider array of data, including diseases, genes, proteins and their structural data, drugs, and drug side effects; 40 pathways, proteins, genes, drugs, diseases, anatomical terms, phenotypes, microbiome; 41 genes, proteins, diseases, phenotypes, genome sequences; 42,43 geographic, viral genes, genes and proteins. 44 Several projects have focused specifically on integrating a wide variety of COVID-19 data to create KGs to investigate drug repurposing.…”